While Kazia Therapeutics Limited ADR has underperformed by -6.76%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KZIA fell by -9.60%, with highs and lows ranging from $17.40 to $2.86, whereas the simple moving average jumped by 13.82% in the last 200 days.
On February 06, 2025, Maxim Group started tracking Kazia Therapeutics Limited ADR (NASDAQ: KZIA) recommending Buy. A report published by Maxim Group on October 14, 2021, Initiated its previous ‘Buy’ rating for KZIA. H.C. Wainwright also rated KZIA shares as ‘Buy’, setting a target price of $17 on the company’s shares in an initiating report dated January 05, 2021.
Analysis of Kazia Therapeutics Limited ADR (KZIA)
Further, the quarter-over-quarter decrease in sales is -98.25%, showing a negative trend in the upcoming months.
In order to gain a clear picture of Kazia Therapeutics Limited ADR’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -3028.18% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.35, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 723.41K can be a very valuable indicator of volatility for KZIA stock. On a monthly basis, the volatility of the stock is set at 25.73%, whereas on a weekly basis, it is put at 21.88%, with a loss of -12.18% over the past seven days. Furthermore, long-term investors anticipate a median target price of $19.00, showing growth from the present price of $8.0, which can serve as yet another indication of whether KZIA is worth investing in or should be passed over.
How Do You Analyze Kazia Therapeutics Limited ADR Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As opposed to executive stock, institutional ownership accounts for 11.16% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
